Our Team
Portfolio
About
News
Insights
Contact
Investor Portal
Careers
OVP Philadelphia Office
50 Monument Road
Suite 201
Bala Cynwyd, PA 19004
Directions
Phone:
484-434-2255
Email:
ovp@osagepartners.com
Media Inquires:
mediarelations@osagepartners.com
Back to insights
Share
University Partners
Aerie Pharmaceuticals Announces Study Results Supporting Additional Mechanism of Action for Lead Glaucoma Drug Candidate AR-13324
prpljess
February 28, 2014
prpljess
Insights
Why We Invested: Returnalyze
James Massaquoi | December 20, 2022
Why We Invested: Curavit
Evan Cannon | November 15, 2022
Why We Invested: TeachFX
Evan Cannon | October 27, 2022
Can You Recession-Proof Your Customers?
Nate Lentz | October 11, 2022
“Big Brain” Software Platforms versus “Small Brain” Best-of-Breed Applications
Nate Lentz | November 3, 2021
Why Your Software Buyer and Sponsor Might Prefer a Multi-Year Contract
Nate Lentz | October 18, 2021
Entrepreneurial Optimism Versus Fraud
Nate Lentz | October 14, 2021
What Should Software Start-up CEOs Be Thinking About As Inflation Risk Rises
Nate Lentz | May 3, 2021
We’re Hiring! Full-Time Analyst (Closed)
OVP Staff | March 12, 2021
Don’t Under-rate the Impact of Leadership – Let FDR Be an Example for Biden, Congress, and the Rest of Us in Stemming the COVID Tide
Nate Lentz | January 13, 2021